$8.10
Today
as of Jul 22, 16:54 ET
Last 30 days
Recent Press Releases & News
Does Solid Biosciences' (SLDB) Russell Growth Index Debut Reveal a Shift in Its Investor Base?
Solid Biosciences and NanoMosaic Announce Co-Marketing Agreement to Advance Gene Therapy Delivery and Analytics
Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Overview
52-week range
$3.67
$8.87
85% of range
Avg surprise (last 3)
-7.9%
Avg reaction (last 2)
+1.0%
100% positive
Latest IV / EM
78%
EM ±17.9% · $8 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue May 12, 2026 | Mar/2026 | $-0.52 | $-0.40 | -30.0% | +11.9% | +0.5% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.48 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.42 | $-0.51 | +17.6% | — | — | earnings |
| Thu May 15, 2025 | Mar/2025 | $-0.59 | $-0.53 | -11.3% | — | +1.6% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.79 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.61 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.64 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.05 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.25 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Tue Aug 11, 2026 | Jun/2026 | OTHER | -$0.43 | -$0.42 | -2.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-57M | — | $-48M | $-42M | $-40M | — | $-35M | $-28M |
| Net income | — | — | — | — | — | — | — | — |
| EPS (diluted) | $-0.52 | — | $-0.48 | $-0.42 | $-0.59 | — | $-0.79 | $-0.61 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $297M | $60M | $61M | $139M | $211M | $80M | $64M | $96M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $397M | $205M | $245M | $279M | $313M | $157M | $179M | $198M |
| Total assets | $423M | $233M | $274M | $308M | $344M | $189M | $212M | $231M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $49M | $53M | $56M | $50M | $49M | $51M | $45M | $38M |
| Total equity | $374M | $180M | $218M | $258M | $294M | $137M | $167M | $193M |